Search

An artificial intelligence (AI)-based model developed by UT Southwestern Medical Center researchers can accurately predict which kidney cancer patients will benefit from anti-angiogenic therapy, a class of treatments that’s only effective in some cases.

A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center researchers suggests.

Welcome to the Department of Anesthesiology and Pain Management at UT Southwestern's website. Our department has a long history of excellence in patient care, key contributions to anesthesia research and outstanding resident training.

UTSW Pediatrics offers 17 Divisions and Centers, 500+ faculty and staff, and 15 ACGME-certified Pediatric Subspecialty Fellowships.

Learn about the Peter O’Donnell Jr. Brain Institute, which tackles the most complex problems in the brain.

Investigator Program The O'Donnell Brain Institute Investigator Program was established to create a mutually beneficial partnership that incorporates the very best brain research happening across UT Southwestern to most effectively and rapidly advance discoveries. In addition, the program fosters sch…

Former postdoctoral immunologist receives Brown-Goldstein Award

The UT Southwestern Division of General and Community Pediatrics provides well-rounded educational training for medical students and residents.

The UT Southwestern Division of General and Community Pediatrics advances the health and well-being of children across backgrounds and medical complexity.

Celebrated viral immunologist Dr. Kizzmekia S. Corbett, who was at the forefront of developing what became the Moderna COVID-19 vaccine, provided insight into its creation and rapid deployment during a virtual presentation at the 2021 Ida M. Green Lecture Honoring Women in Science and Medicine. Currently one of the nation’s most in-demand speakers, Dr. Corbett described how the candidate vaccine, in just a few months, went from scientific concept at the National Institutes of Health (NIH) to national distribution of a two-dose regimen that has shown to be more than 90 percent effective.